Abicipar Pegol

DB12258InvestigationalProtein Based Therapies

Abicipar Pegol has been used in trials studying the treatment of Macular Edema and Macular Degeneration.

Mechanism: Pharmacologically active on Vascular endothelial growth factor A, long form
Curator reviewed
Code names: AGN-150998

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

36Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 8 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Abicipar Pegol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.